Aster Capital Management’s Replimune Group REPL Stock Holding History
Bought
Maintained
Sold
Other funds holding REPL
BBA
RI
RCI
SCM
BCM
FIS
Aster Capital Management's REPL Position: Q2 2026 in Review
Aster Capital Management increased its Replimune Group (REPL) stake by 2,787% in Q2 2026, buying an estimated $43.5K and bringing the position to 7,362 shares worth $81.5K. The position accounts for 0.02% of the portfolio, ranked #507.
Aster Capital Management first reported a position in REPL in Q3 2024 and has held it in 5 quarters since. The position peaked at $100K in Q4 2024. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.
- Aster Capital Management held 7,362 shares of Replimune Group worth $81.5K as of Q2 2026.
- Aster Capital Management bought 7,107 Replimune Group shares in Q2 2026, an estimated $43.5K.
- Replimune Group made up 0.02% of Aster Capital Management's portfolio in Q2 2026, its #507 holding.
- Aster Capital Management first reported a position in Replimune Group in Q3 2024 and has held it in 5 quarters since.
- Aster Capital Management's Replimune Group position peaked at $100K in Q4 2024.
- 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.
Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.